Scientists offer cell surface engineering as an alternative method for creating erythrocyte drug carriers. This allows for more effective drug loading or improved efficacy without modifying the morphological or functional characteristics of erythrocytes. We are able to address the unique requirements of our customers using a variety of cell surface engineering techniques utilizing large surface functional groups on erythrocytes, such as amino acids, thiol groups, sugars, and lipids. This is made possible by our advanced platforms and significant knowledge. By using these customized strategies, we increase productivity and provide time and money savings. Creative Biolabs may offer a variety of erythrocyte-based conjugates, such as but not restricted to:

Conjugated erythrocyte and antibody
Drug-erythrocyte combination

A combination of fluorescent protein and erythrocyte
For more: erythrocytes surface engineering